Bernstein AB Stock Entry Strategy Overview Q4 2025 EPS Exceeds Expectations Should I sell Foghorn Therapeutics FHTX stock today Q4 2025 Earnings Underperform What Foghorn Therapeutics FHTX is doing to win in its industry Q4 2025 Earnings Underperform HOFT Hooker shares rally 35 despite missing Q1 earnings by 30 percent Appeals Court Grants Trump Delay in 83 Million Defamation Payment Orders 74 Million Bond Trumps Crypto Venture and Irans Top Exchange Share Same Blockchain Networks Reuters Analysis MuskAltman Trial Exposes Techs Troubled Underbelly Five Key Revelations Emerge UK Gilt Yields and Pound Slide Amid Political Uncertainty Over Burnham Leadership Speculation